share_log

Cannabis Global Provides Patent Applications Update – For Its Cannabis Nanoparticles And Insect Produced Cannabosides

Cannabis Global Provides Patent Applications Update – For Its Cannabis Nanoparticles And Insect Produced Cannabosides

Cannabis Global提供专利申请更新——针对其大麻纳米颗粒和昆虫生产的大麻苷
Benzinga Real-time News ·  2022/08/16 10:54

Cannabis Global, Inc. (OTCPK:CBGL) provided an update concerning the company's patent applications, especially relating to its application to protect inventions and processes for cannabis nanoparticles.

大麻环球公司 (OTCPK: CBGL) 提供了有关 c公司的专利申请, 特别是关于将其应用于保护以下方面的发明和工艺 大麻纳米颗粒。

Cannabis Global continues to pursue two non-provisional patent applications for cannabis technologies. The first of these relates to the use of state-of-the-art production devices to produce nanoparticles and nanofibers made from cannabinoids. These tiny "pieces" of cannabinoids are only between 100 nanometers and 700 nanometers wide, which is as small as less than 1% of the width of a human hair. Cannabis Global plans to use this technology to provide more efficient dosing of cannabinoids in a variety of new products, such as pharmaceuticals, food, beverages, and topical skin preparations.

Cannabis Global继续为大麻技术申请两项非临时专利。其中第一个问题涉及使用最先进的生产技术 生产由大麻素制成的纳米颗粒和纳米纤维的设备。 这些微小的大麻素 “碎片” 的宽度仅在100纳米至700纳米之间,小到人类头发宽度的1%。Cannabis Global计划使用这项技术在药品、食品、饮料和外用皮肤制剂等各种新产品中提供更高效的大麻素剂量。

The non-provisional filing occurred on July 8, 2021 and is currently being reviewed by the U.S patent office. In addition, earlier this month, the company responded to clarifications posed by the U.S. patent office relative to the priority the company wished to be given to the several separate inventions within the application.

该非临时申请于 2021 年 7 月 8 日提出,目前正在接受美国专利局的审查。此外,本月早些时候,c公司对美国专利局的澄清做出了回应 相对于公司希望获得申请中几项单独发明的优先权。

In addition, Cannabis Global has filed for protection for inventions relating to the creation of cannabosides, which are modifications of the naturally occurring, plant-based cannabinoids that could potentially significantly increase the bio-absorption of cannabis-related compounds by the human body. In the case of the company's technology to create cannabosides, non-THC containing hemp or THC containing cannabis are fed to insects, which convert the cannabinoids within the feedstock into cannabosides. The company filed the non-provisional patent on January 18, 2021.

此外,Cannabis Global已申请保护与创作有关的发明 大麻苷,它们是对天然存在的植物性大麻素的修饰,有可能显著增加人体对大麻相关化合物的生物吸收。就公司制造大麻苷的技术而言,不含四氢大麻酚的大麻酚或含有四氢大麻酚的四氢大麻酚 大麻被喂给昆虫,昆虫将原料中的大麻素转化为大麻苷。 该公司于2021年1月18日申请了非临时专利。

Cannabis Global has also filed for international protection for both categories of these inventions from the International Patent Cooperation Union (PCT). The PCT assists applicants in seeking patent protection internationally for their inventions, helps patent offices with their patent granting decisions and facilitates public access to a wealth of technical information relating to those inventions. By filing one international patent application under the PCT, applicants can simultaneously seek protection for an invention in numerous countries via a single application.

Cannabis Global还向国际专利合作联盟(PCT)申请了对这两类发明的国际保护。PCT协助申请人为其发明寻求国际专利保护,帮助专利局做出专利授予决定,并促进公众获得与这些发明有关的大量技术信息。通过根据PCT提交一份国际专利申请,申请人可以通过一份申请同时在多个国家为一项发明寻求保护。

Photo by Louis Reed on Unsplash

照片由路易斯·里德在 Unsplash

Related News

相关新闻

From Hash 2.0 To El Cheapo, Cannabis Global Prepares For Launch Of 23 New Cannabis Products

从 Hash 2.0 到 El Cheapo,Cannabis Global 为推出 23 种新的大麻产品做准备

Cannabis Global Enters Into Supply Agreement For 'Fresh Frozen' Cannabis With Sugarmade

Cannabis Global 与 Sugarmade 签订了 “新鲜冷冻” 大麻的供应协议

Cannabis Global Financial Results For The Quarter Show Staggering Revenue Growth Of 2,330% YoY

本季度大麻全球财务业绩显示收入同比增长惊人 2,330%

 

 

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发